Found: 57
Select item for more details and to access through your institution.
Domains of baseless belief and the characteristics of believers.
- Published in:
- Social Science Quarterly (Wiley-Blackwell), 2024, v. 105, n. 6, p. 1892, doi. 10.1111/ssqu.13448
- By:
- Publication type:
- Article
Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1.
- Published in:
- Frontiers in Pediatrics, 2024, p. 1, doi. 10.3389/fped.2024.1465166
- By:
- Publication type:
- Article
How Including Prior Knowledge As a Subject Variable May Change Outcomes of Learning Research.
- Published in:
- American Educational Research Journal, 2004, v. 41, n. 1, p. 159, doi. 10.3102/00028312041001159
- By:
- Publication type:
- Article
Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study.
- Published in:
- Patient Preference & Adherence, 2017, v. 11, p. 1603, doi. 10.2147/PPA.S141389
- By:
- Publication type:
- Article
A validated measure of adherence to antibiotic prophylaxis in children with sickle cell disease.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 983, doi. 10.2147/PPA.S103874
- By:
- Publication type:
- Article
Training Professionals in Delivering Evidence-based Cognitive Rehabilitation.
- Published in:
- Brain Injury Professional, 2021, v. 17, n. 4, p. 27
- By:
- Publication type:
- Article
An investigation of the cognitive processes underlying the keyword method of foreign vocabulary learning.
- Published in:
- Language Teaching Research, 2005, v. 9, n. 2, p. 129, doi. 10.1191/1362168805lr151oa
- By:
- Publication type:
- Article
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE<sup>®</sup>) in the management of hemophilia A.
- Published in:
- Vascular Health & Risk Management, 2007, v. 3, n. 5, p. 555
- By:
- Publication type:
- Article
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE) in the management of hemophilia A.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Cytomegalovirus (CMV) Retinitis Activity Is Accurately Reflected by the Presence and Level of CMV DNA in Aqueous Humor and Vitreous.
- Published in:
- Journal of Infectious Diseases, 1999, v. 179, n. 5, p. 1249, doi. 10.1086/314710
- By:
- Publication type:
- Article
Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 1, p. 113, doi. 10.1111/bjh.13109
- By:
- Publication type:
- Article
Prophylaxis with recombinant factor IX Fc fusion protein reduces the risk of bleeding and delays time to first spontaneous bleed event in previously untreated patients with haemophilia B: A post hoc analysis of the PUPs B‐LONG study.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 4, p. 485, doi. 10.1111/ejh.14252
- By:
- Publication type:
- Article
Recombinant factor IX Fc for the treatment of hemophilia B.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 5, p. 678, doi. 10.1111/ejh.14176
- By:
- Publication type:
- Article
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 3, p. 232, doi. 10.1111/ejh.13731
- By:
- Publication type:
- Article
Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Priming correct information reduces the misinformation effect.
- Published in:
- Memory & Cognition, 2012, v. 40, n. 5, p. 717, doi. 10.3758/s13421-012-0191-7
- By:
- Publication type:
- Article
Forgetting of verbatim information in discourse.
- Published in:
- Memory & Cognition, 1994, v. 22, n. 1, p. 85, doi. 10.3758/BF03202764
- By:
- Publication type:
- Article
Safety of high doses of a monoclonal antibody-purified factor IX concentrate.
- Published in:
- American Journal of Hematology, 1995, v. 49, n. 1, p. 92, doi. 10.1002/ajh.2830490117
- By:
- Publication type:
- Article
Excess of red cell membrane proteins in hereditary high-phosphatidylcholine hemolytic anemia.
- Published in:
- American Journal of Hematology, 1990, v. 34, n. 3, p. 186, doi. 10.1002/ajh.2830340306
- By:
- Publication type:
- Article
Repeated recall as an intervention to improve memory performance in heart failure patients.
- Published in:
- European Journal of Cardiovascular Nursing, 2017, v. 16, n. 8, p. 724, doi. 10.1177/1474515117711610
- By:
- Publication type:
- Article
Hypermedia design as learner scaffolding.
- Published in:
- Educational Technology Research & Development, 2008, v. 56, n. 1, p. 29, doi. 10.1007/s11423-007-9063-4
- By:
- Publication type:
- Article
Clinical application of recommendations for neurobehavioral assessment in disorders of consciousness: an interdisciplinary approach.
- Published in:
- Frontiers in Human Neuroscience, 2023, p. 1, doi. 10.3389/fnhum.2023.1129466
- By:
- Publication type:
- Article
Case Report: Respiratory lesions successfully treated with intravenous plasminogen, human-tvmh, replacement therapy in four patients with plasminogen deficiency type 1.
- Published in:
- Frontiers in Pediatrics, 2024, p. 1, doi. 10.3389/fped.2024.1465166
- By:
- Publication type:
- Article
Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Variable bleeding phenotype in an Amish pedigree with von Willebrand disease.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. E431, doi. 10.1002/ajh.24474
- By:
- Publication type:
- Article
Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura.
- Published in:
- American Journal of Hematology, 2005, v. 79, n. 3, p. 175, doi. 10.1002/ajh.20299
- By:
- Publication type:
- Article
Final Results of the Prospective ADVATE<sup>®</sup> Immune Tolerance Induction Registry (PAIR) Study with Plasma- and Albumin-Free Recombinant Factor VIII.
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 991, doi. 10.2147/JBM.S329883
- By:
- Publication type:
- Article
Treatment of Nonsuicidal Self-Injury: Critical Review and Implications for School Applications.
- Published in:
- School Psychology Forum, 2013, v. 7, n. 4, p. 121
- By:
- Publication type:
- Article
Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS‐Hemo platform.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 988, doi. 10.1111/hae.15027
- By:
- Publication type:
- Article
Plasminogen, human‐tvmh for the treatment of children and adults with plasminogen deficiency type 1.
- Published in:
- Haemophilia, 2023, v. 29, n. 6, p. 1556, doi. 10.1111/hae.14849
- By:
- Publication type:
- Article
Psychometrics and applications of a novel self‐report measure of emicizumab adherence: VERITASNexGen.
- Published in:
- Haemophilia, 2023, v. 29, n. 5, p. 1299, doi. 10.1111/hae.14851
- By:
- Publication type:
- Article
Severe FVII deficiency presenting with heterotopic gastric mucosa: hoofbeats may be a zebra.
- Published in:
- Haemophilia, 2023, v. 29, n. 3, p. 928, doi. 10.1111/hae.14782
- By:
- Publication type:
- Article
Global epidemiology of factor XI deficiency: A targeted review of the literature and foundation reports.
- Published in:
- Haemophilia, 2023, v. 29, n. 2, p. 423, doi. 10.1111/hae.14687
- By:
- Publication type:
- Article
Therapeutic and technological advancements in haemophilia care: Quantum leaps forward.
- Published in:
- Haemophilia, 2022, v. 28, p. 77, doi. 10.1111/hae.14531
- By:
- Publication type:
- Article
Therapeutic and technological advancements in haemophilia care: Quantum leaps forward.
- Published in:
- Haemophilia, 2022, v. 28, p. 77, doi. 10.1111/hae.14531
- By:
- Publication type:
- Article
Occurrence rates of inherited bleeding disorders other than haemophilia and von Willebrand disease among people receiving care in specialized treatment centres in the United States.
- Published in:
- Haemophilia, 2022, v. 28, n. 3, p. e75, doi. 10.1111/hae.14529
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. i, doi. 10.1111/hae.14463
- By:
- Publication type:
- Article
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 921, doi. 10.1111/hae.14419
- By:
- Publication type:
- Article
The effect of emicizumab prophylaxis on long‐term, self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 854, doi. 10.1111/hae.14363
- By:
- Publication type:
- Article
The B‐Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 802, doi. 10.1111/hae.14357
- By:
- Publication type:
- Article
Management of people with haemophilia A undergoing surgery while receiving emicizumab prophylaxis: Real‐world experience from a large comprehensive treatment centre in the US.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 90, doi. 10.1111/hae.14212
- By:
- Publication type:
- Article
Real‐world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow‐up retrospective analysis.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 19, doi. 10.1111/hae.14192
- By:
- Publication type:
- Article
Natural history study of factor IX deficiency with focus on treatment and complications (B‐Natural).
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 49, doi. 10.1111/hae.14139
- By:
- Publication type:
- Article
Real‐world data demonstrate improved bleed control and extended dosing intervals for patients with haemophilia B after switching to recombinant factor IX Fc fusion protein (rFIXFc) for up to 5 years.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 975, doi. 10.1111/hae.14152
- By:
- Publication type:
- Article
Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. e262, doi. 10.1111/hae.14036
- By:
- Publication type:
- Article
Adherence is a human behaviour, assessing it requires multimethod evaluation with validated measures: Comment on Guedes VG et al (2019).
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 934, doi. 10.1111/hae.14022
- By:
- Publication type:
- Article
Potential of the Community Counts registry to characterize rare bleeding disorders.
- Published in:
- Haemophilia, 2019, v. 25, n. 6, p. 1045, doi. 10.1111/hae.13847
- By:
- Publication type:
- Article
Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency.
- Published in:
- Haemophilia, 2019, v. 25, n. 6, p. 1073, doi. 10.1111/hae.13842
- By:
- Publication type:
- Article
Factor VIII prophylaxis effects outweigh other hemostasis contributors in predicting severe haemophilia A joint outcomes.
- Published in:
- Haemophilia, 2019, v. 25, n. 5, p. 867, doi. 10.1111/hae.13778
- By:
- Publication type:
- Article
Population‐based surveillance of haemophilia and patient outcomes in Indiana using multiple data sources.
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. 456, doi. 10.1111/hae.13734
- By:
- Publication type:
- Article